Alexey A. Matskevich
Hoofd Techniek/Wetenschap/O&O bij TheraMAB LLC
Actieve functies van Alexey A. Matskevich
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
TheraMAB LLC
 TheraMAB LLC BiotechnologyHealth Technology TheraMAB LLC develops immunotherapeutic monoclonal antibody. It focuses on the development of potential drug that, by its unique capacity to selectively modulate the activity of T-lymphocytes, may provide new treatment options for major diseases in the field of autoimmunity and cancer. The company was founded in August 2009 and is headquartered in Moscow, Russia. | Hoofd Techniek/Wetenschap/O&O | - | - |
Loopbaan van Alexey A. Matskevich
Eerdere bekende functies van Alexey A. Matskevich
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| University of Lausanne | Corporate Officer/Principal | 01-01-2009 | 01-01-2009 |
| University of Zurich | Corporate Officer/Principal | 01-01-2008 | 01-01-2008 |
| University of Strasbourg | Corporate Officer/Principal | 01-01-2005 | 01-01-2005 |
Opleiding van Alexey A. Matskevich
| Moscow State University Lomonosov | Doctorate Degree |
Statistieken
Internationaal
| Rusland | 3 |
| Zwitserland | 3 |
| Frankrijk | 2 |
Operationeel
| Corporate Officer/Principal | 3 |
| Chief Tech/Sci/R&D Officer | 1 |
| Doctorate Degree | 1 |
Sectoraal
| Consumer Services | 5 |
| Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
TheraMAB LLC
TheraMAB LLC BiotechnologyHealth Technology TheraMAB LLC develops immunotherapeutic monoclonal antibody. It focuses on the development of potential drug that, by its unique capacity to selectively modulate the activity of T-lymphocytes, may provide new treatment options for major diseases in the field of autoimmunity and cancer. The company was founded in August 2009 and is headquartered in Moscow, Russia. | Health Technology |
